Product Information
TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB is a generic product labeled by Solco Healthcare US LLC, priced at $0.3678 per EA under NDC 43547044103. Its NADAC has been published 417 times since Aug 29, 2018.
FDA first approved this application on Nov 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 40 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547044103
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA209028FDA Approved
11/6/2017
TE Code
AB
On Market Since
2/5/2018
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has been published 417 times since Aug 29, 2018, and over the history we have for it it has declined 79.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3678 per EA |
|---|---|
| All-time high | $2.2627 (Jul 10, 2019) |
| All-time low | $0.2777 (Nov 20, 2024) |
| 52-week high | $0.4067 |
| 52-week low | $0.3484 |
| Median price | $0.8727 |
| Average price | $1.0351 |
| Largest weekly change | +83.5% (Nov 22, 2023) |
| Weeks tracked | 417 |
| Tracking since | Aug 29, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, manufactured by Solco Healthcare US LLC, is $0.3678 per EA (NDC 43547044103), effective Aug 19, 2026.
How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has declined 79.3%. It has been tracked across 417 weekly CMS publications since Aug 29, 2018.
What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
Since Aug 29, 2018, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has ranged from a low of $0.2777 (Nov 20, 2024) to a high of $2.2627 (Jul 10, 2019), with a median of $0.8727 per EA.
Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?
TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB (NDC 43547044103) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.